Furthermore, risk-factor awareness among patients with lower-limb ischemia is suboptimal, and one benefit of a NLC is the opportunity to educate patients.(24,25) Indeed, our results show significant benefits of a protocol-based NLC for claudicants with a 25% relative risk reduction of predicted 10-year coronary events over a 3-month period.